Benefit of Elevation of HDL-C in Women

The combination of HDL-C elevation, lowering of triglycerides and further LDL-C reduction accomplished by the addition of niacin to statin medication would improve endothelial function as compared to ...

Lead sponsor: Cedars-Sinai Medical Center•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

COMPLETED

Air Pollution and Cardiometabolic Study

NCT02601352 · Cardiovascular Outcomes

WITHDRAWNPhase 4

Cardiovascular Risk Following Conversion to Full Dose Myfortic® and Neoral® Two-hour Post Level Monitoring

NCT02058875 · Cardiovascular Disease, Cardiovascular Outcomes, and more

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 23, 2019Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE4

Enrollment43

Start dateJun 2003

Last updatedApr 23, 2019

Condition

Cardiovascular Outcomes

Locations shown

Cedars-Sinai Medical Center

Los Angeles, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 23, 2019Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions